Shares of Diploma PLC (LON:DPLM – Get Free Report) have earned an average recommendation of “Moderate Buy” from the seven brokerages that are covering the stock, Marketbeat Ratings reports. Three investment analysts have rated the stock with a hold rating and four have issued a buy rating on the company. The average 1-year target price among brokers that have issued ratings on the stock in the last year is GBX 5,634.29.
A number of equities analysts have recently issued reports on DPLM shares. Deutsche Bank Aktiengesellschaft increased their price objective on shares of Diploma from GBX 6,000 to GBX 6,200 and gave the stock a “buy” rating in a research report on Wednesday, January 14th. Peel Hunt reaffirmed a “buy” rating and issued a GBX 6,150 target price on shares of Diploma in a research report on Friday, December 19th. Finally, Berenberg Bank reaffirmed a “buy” rating and set a GBX 6,350 price target on shares of Diploma in a research note on Wednesday, November 19th.
View Our Latest Stock Analysis on Diploma
Insider Transactions at Diploma
Diploma Stock Down 3.8%
Shares of LON DPLM opened at GBX 5,105 on Monday. The company has a quick ratio of 0.80, a current ratio of 2.04 and a debt-to-equity ratio of 46.97. The firm has a market cap of £6.85 billion, a PE ratio of 37.18, a P/E/G ratio of 2.82 and a beta of 1.03. The company’s fifty day simple moving average is GBX 5,478.66 and its 200 day simple moving average is GBX 5,432.61. Diploma has a 12-month low of GBX 3,532 and a 12-month high of GBX 5,760.
Diploma (LON:DPLM – Get Free Report) last posted its quarterly earnings results on Monday, December 8th. The company reported GBX 176 earnings per share for the quarter. Diploma had a net margin of 8.99% and a return on equity of 14.17%. As a group, sell-side analysts forecast that Diploma will post 163.7995512 earnings per share for the current fiscal year.
About Diploma
Diploma PLC, together with its subsidiaries, supplies specialized technical products and services in the United Kingdom, Continental Europe, North America, and internationally. It operates through three business sectors: Life Sciences, Seals, and Controls. The Life Sciences sector supplies technology-enabled products used in surgical procedures in operating theatres and endoscopy; testing equipment and services for clinical laboratories; and bio-pharma, food safety and testing, and other research-oriented products.
Read More
- Five stocks we like better than Diploma
- The gold chart Wall Street is terrified of…
- America’s 1776 happening again
- What a Former CIA Agent Knows About the Coming Collapse
- Elon Musk already made me a “wealthy man”
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
Receive News & Ratings for Diploma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Diploma and related companies with MarketBeat.com's FREE daily email newsletter.
